Abstract
Measles antibody was measured in three groups of children: (1) those who had received live measles virus vaccine at less than 1 year of age, (2) previously immunized siblings of children with clinical measles at the time of this study, and (3) previously immunized children who were revaccinated with live further attenuated measles virus vaccine. The results of this study indicated that children who have received live measles virus vaccine at less than 1 year of age, particularly less than 11 months, have very low antibody levels and may need revaccination. This can be accomplished in many children with the live further attenuated measles virus vaccine. However, following exposure to natural measles, many previously immunized children will experience a natural boost in titer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
